Amwell (AMWL) Stock
Key stats
- Market cap
- $211.98M
- Price / Earnings ratio
- -3.6x
- EPS (TTM)
- -$3.44
- Volume
- Loading
- 52-week high
- $15.16
- 52-week low
- $3.71
- EPS vs analyst estimate
- -24.2%Q3 FY25 · -$2.00 vs -$1.61
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with AMWL
Recent news

What American Well (AMWL) Said on Its Q3 Earnings Call
What American Well (AMWL) Said on Its Q3 Earnings Call
AMWL

American Well Corporation (AMWL) Reports Q3 Loss, Tops Revenue Estimates
American Well Corporation (AMWL) Reports Q3 Loss, Tops Revenue Estimates
AMWL

American Well (AMWL) Surges 6.1%: Is This an Indication of Further Gains?
American Well (AMWL) Surges 6.1%: Is This an Indication of Further Gains?
AMWL

Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
AMWL
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 45.99
- MACD 12/26/9
- -0.19
- EMA 9 of MACD
- -0.05
- MACD histogram
- -0.14
- SMA 50
- $12.98
- Price below SMA 50
- EMA 50
- $12.64
- Price below EMA 50
- SMA 200
- $9.23
- Price above SMA 200
- EMA 200
- $9.41
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Hold
Based on 3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of -$1.45 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

What American Well (AMWL) Said on Its Q3 Earnings Call
What American Well (AMWL) Said on Its Q3 Earnings Call
AMWL

American Well Corporation (AMWL) Reports Q3 Loss, Tops Revenue Estimates
American Well Corporation (AMWL) Reports Q3 Loss, Tops Revenue Estimates
AMWL

American Well (AMWL) Surges 6.1%: Is This an Indication of Further Gains?
American Well (AMWL) Surges 6.1%: Is This an Indication of Further Gains?
AMWL

Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
Zacks Industry Outlook Medical Systems, American Well and Butterfly Network
AMWL

3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
3 Medical Info Systems Stocks to Gain From GenAI Boom Amid Cyber Risk
AMWL

American Well (AMWL) Upgraded to Buy: What Does It Mean for the Stock?
American Well (AMWL) Upgraded to Buy: What Does It Mean for the Stock?
AMWL

Here Is Why Bargain Hunters Would Love Fast-paced Mover American Well (AMWL)
Here Is Why Bargain Hunters Would Love Fast-paced Mover American Well (AMWL)
AMWL

American Well Q2 Earnings Call Highlights
American Well Q2 Earnings Call Highlights
AMWL

American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates
American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates
AMWL

American Well (AMWL) Soars 11.1%: Is Further Upside Left in the Stock?
American Well (AMWL) Soars 11.1%: Is Further Upside Left in the Stock?
AMWL
News tone: automated (AI) classification of the article's content, not a price prediction.
About Amwell
Amwell is a leading telehealth platform in the United States and globally, connecting and enabling providers, insurers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that digital care delivery will transform healthcare. The Company offers a single, comprehensive platform to support all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Ido Schoenberg M.D. | Chairman & CEO | 1965 |
| Mr. Mark J. Hirschhorn CPA | Executive VP, COO & CFO | 1965 |
| Mr. Dan Zamansky | Chief Product & Technology Officer | 1984 |
| Mr. Paul Francis McNeice | Vice President of Accounting | 1977 |
| Anna Nesterova | Head of Legal & Deputy General Counsel | — |
| Mr. Michael Miller | Senior Vice President & Chief Sales Officer | — |
| Ms. Phyllis I. Gotlib | President of Amwell International | 1958 |
| Dr. Cynthia Horner FAAFP, M.D. | Chief Medical Officer & President of Amwell Medical Group | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 45.99
- MACD 12/26/9
- -0.19
- EMA 9 of MACD
- -0.05
- MACD histogram
- -0.14
- SMA 50
- $12.98
- Price below SMA 50
- EMA 50
- $12.64
- Price below EMA 50
- SMA 200
- $9.23
- Price above SMA 200
- EMA 200
- $9.41
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $12.00
- Average
- $13.75
- High
- $18.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -23.9 | -2.9 | ||||||||||
| 2022 | -23.6 | -13.5 | +7.7 | -28.0 | +14.5 | +22.0 | -11.8 | +12.6 | -17.1 | +6.5 | -9.4 | -24.9 |
| 2023 | +40.8 | -30.4 | -14.5 | -5.2 | +1.4 | -8.3 | +16.7 | -38.3 | -21.5 | +4.5 | +7.6 | +14.6 |
| 2024 | -27.6 | -0.9 | -23.5 | -33.8 | -19.6 | -22.6 | +60.2 | -26.1 | +21.4 | -1.0 | +6.3 | -21.4 |
| 2025 | +53.1 | -7.7 | -9.9 | +2.2 | +8.9 | +35.1 | -12.5 | -1.6 | -8.9 | -15.5 | -16.9 | +22.4 |
| 2026 | -6.2 | +24.5 | -0.8 | +19.5 | +60.6 | +0.8 | +14.7 | +11.2 | +12.5 | -0.7 | -4.0 |
Corporate actions
Upcoming
No upcoming corporate actions for AMWL



